March Sales











































I did an in service in a key group the other day. One of my customers was so excited when I started into sharing data on Z, he excused himself with his salad- left and never came back again. I later approached him about this and he said he is "good" on Diclofenac.
 






This is brutal! Working off a crappy target list, highest copay of the brands, and the topper is the recent clarification of our $500 per month budget for the year! I go to pharmacies and they give me the names of high diclofenac rxers and the fact I have no incentive to call on them because they are not on my target list is horse....! This is remedial pharma at best.
 






I did an in service in a key group the other day. One of my customers was so excited when I started into sharing data on Z, he excused himself with his salad- left and never came back again. I later approached him about this and he said he is "good" on Diclofenac.

Clearly your fault for not properly presenting the pillars of the Z story and gaining "buy-in" on the scientific rationale and the need for a low dose product for his patients!... This will reflect on your mid year review as poor ability in selling skills
 






Clearly your fault for not properly presenting the pillars of the Z story and gaining "buy-in" on the scientific rationale and the need for a low dose product for his patients!... This will reflect on your mid year review as poor ability in selling skills

Please elaborate on the scientific rationale. Sub-micron powder, improved PK, low dose which leads to:

- A safer diclofenac
- With equal efficacy to the higher strength generic diclofenac*

*That would be a good story but unfortunately PK data can not be correlated with clinical safety and efficacy.
 






Please elaborate on the scientific rationale. Sub-micron powder, improved PK, low dose which leads to:

- A safer diclofenac
- With equal efficacy to the higher strength generic diclofenac*

*That would be a good story but unfortunately PK data can not be correlated with clinical safety and efficacy.

Safer???....awesome. Prove it!
 












Please elaborate on the scientific rationale. Sub-micron powder, improved PK, low dose which leads to:

- A safer diclofenac
- With equal efficacy to the higher strength generic diclofenac*

*That would be a good story but unfortunately PK data can not be correlated with clinical safety and efficacy.

You are right on! You can explain it much better than most of my DM counterparts. You are doing the best you can with the information we can promote from.
 






Next push will be desperate DM's asking reps to push the ethical boundaries and compromise their credibility to say things we cannot prove. Don't do it. It's not worth loosing your credibility in the long run of your career.
 






I had a script filled for myself about two weeks ago. Someone tell me why taking Zorvolex would give me took hard bonkers about four times per day...never had a problem with performance...but these massive erections are....... Well... Spontaneous?????
 






Dangerous trend towards off label selling. Claims about safer diclofenac or equivalent efficacy are unfounded and not backed by clinical data or trials.

Iroko - gearing up to get the quickest CIA in history. Hope they have the cash to pay the fine!!!
 


















I dont agree , how many reps are getting docs to write for 7 days, 10 days- were we trained on this?
The dosing for Zorvolex is 3 times a day . Explain how a rep can get equal credit for a 7 day RX .
Does the company not make more money off of a 30 day RX? Seems like the rep who had a doc write the 30 day RX should receive more credit than a 7 day RX?